Literature DB >> 27680739

[Cardiovascular outcome in patients with COPD : Study to Understand Mortality and Morbidity (SUMMIT)].

T Welte1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27680739     DOI： 10.1007/s00108-016-0139-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  6 in total

1.  Acute exacerbation of chronic obstructive pulmonary disease: more a functional than an inflammatory problem?

Authors:  Tobias Welte
Journal:  Am J Respir Crit Care Med       Date:  2008-01-15       Impact factor: 21.405

2.  The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.

Authors:  Annika Karch; Claus Vogelmeier; Tobias Welte; Robert Bals; Hans-Ulrich Kauczor; Jürgen Biederer; Joachim Heinrich; Holger Schulz; Sven Gläser; Rolf Holle; Henrik Watz; Stephanie Korn; Nina Adaskina; Frank Biertz; Charlotte Vogel; Jørgen Vestbo; Emiel F M Wouters; Klaus Friedrich Rabe; Sandra Söhler; Armin Koch; Rudolf A Jörres
Journal:  Respir Med       Date:  2016-03-11       Impact factor: 3.415

3.  [Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET].

Authors:  R A Jörres; T Welte; R Bals; A Koch; M Schnoor; C Vogelmeier
Journal:  Dtsch Med Wochenschr       Date:  2010-03-02       Impact factor: 0.628

4.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

5.  Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

Authors:  Jadwiga A Wedzicha; Donald Banerji; Kenneth R Chapman; Jørgen Vestbo; Nicolas Roche; R Timothy Ayers; Chau Thach; Robert Fogel; Francesco Patalano; Claus F Vogelmeier
Journal:  N Engl J Med       Date:  2016-05-15       Impact factor: 91.245

6.  Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Authors:  David A Stempel; Ibrahim H Raphiou; Kenneth M Kral; Anne M Yeakey; Amanda H Emmett; Charlene M Prazma; Kathleen S Buaron; Steven J Pascoe
Journal:  N Engl J Med       Date:  2016-03-06       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.